Brian Druker博士,癌症研究先锋,由于对财务重点的担心而辞去OHSU职务。 Dr. Brian Druker, cancer research pioneer, resigns from OHSU due to concerns over financial focus.

俄勒冈州卫生和科学大学骑士癌症研究所首席执行官Brian Druker博士辞职,理由是重点转向研究和病人护理的资金。 Dr. Brian Druker, CEO of the Knight Cancer Institute at Oregon Health & Science University (OHSU), has resigned, citing a shift in focus towards finances over research and patient care. Druker是白血病治疗的先锋,他将回到实验室研究和病人护理工作。 Druker, a pioneer in leukemia treatment, will return to lab research and patient care. 在他离开之前,在OHSU发生了一年的动乱,包括大学校长和首席执行官辞职,以及目前的财政和行政挑战。 His departure follows a year of turmoil at OHSU, including the resignations of the university president and CEO, and ongoing financial and administrative challenges.